Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-chloroprocaine
2. Chlor-procaine
3. Chloroprocaine
4. Nesacaine
5. Nesacaine Mpf
1. 3858-89-7
2. Chloroprocaine Hcl
3. Chloroprocaine (hydrochloride)
4. 2-chloroprocaine Hydrochloride
5. Nesacaine
6. Chebi:3637
7. 2-chloroprocaine;halestyn; Piocaine
8. 2-diethylaminoethyl 4-amino-2-chlorobenzoate Hydrochloride
9. 2-(diethylamino)ethyl 4-amino-2-chlorobenzoate;hydrochloride
10. 2-(diethylamino)ethyl 4-amino-2-chlorobenzoate Monohydrochloride
11. 2-(diethylamino)ethyl 4-amino-2-chlorobenzoate Hydrochloride
12. Lt7z1yw11h
13. Chloroprocaine Hydrochloride (usp)
14. 4-amino-2-chlorobenzoic Acid 2-(diethylamino)ethyl Ester Hydrochloride
15. Benzoic Acid, 4-amino-2-chloro-, 2-(diethylamino)ethyl Ester, Monohydrochloride
16. Ncgc00183273-01
17. Clorotekal (tn)
18. Nesacaine (tn)
19. Clorotekal
20. Chloroprocainhydrochlorid
21. Chloroprocainehydrochloride
22. Chembl944
23. Chlorprocaine Chloride
24. Dsstox_cid_28521
25. Dsstox_rid_82793
26. Dsstox_gsid_48595
27. Schembl24096
28. Dtxsid6048595
29. Hy-b1604
30. Tox21_112925
31. S4284
32. Ccg-267543
33. Chloroprocaine Hydrochloride [mi]
34. Cas-3858-89-7
35. Chloroprocaine Hydrochloride [mart.]
36. Chloroprocaine Hydrochloride [vandf]
37. Chloroprocaine Hydrochloride [usp-rs]
38. Chloroprocaine Hydrochloride [who-dd]
39. Cs-0013536
40. Sw220257-1
41. A14260
42. D00732
43. 858c897
44. A912305
45. Chloroprocaine Hydrochloride [orange Book]
46. Chloroprocaine Hydrochloride [usp Monograph]
47. W-106476
48. Q27068150
49. Chloroprocaine Hydrochloride 1000 Microg/ml In Methanol
50. 2-(diethylamino)ethyl 4-amino-2-chlorobenzoate Hcl
51. Benzoic Acid,4-amino-2-chloro-,2-(diethylamino)ethyl Ester
52. [2-(4-amino-2-chloro-benzoyloxy)-ethyl]-diethyl-ammonium; Chloride
53. 4-amino-2-chlorobenzoicacid2-(diethylamino)ethylesterhydrochloride
54. Benzoic Acid,4-amino-2-chloro-, 2-(diethylamino)ethyl Ester
Molecular Weight | 307.21 g/mol |
---|---|
Molecular Formula | C13H20Cl2N2O2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 7 |
Exact Mass | 306.0901833 g/mol |
Monoisotopic Mass | 306.0901833 g/mol |
Topological Polar Surface Area | 55.6 Ų |
Heavy Atom Count | 19 |
Formal Charge | 0 |
Complexity | 259 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Chloroprocaine hydrochloride |
Drug Label | Nesacaine and Nesacaine-MPF Injections are sterile non pyrogenic local anesthetics. The active ingredient in Nesacaine and Nesacaine-MPF Injections is chloroprocaine HCL (benzoic acid, 4-amino-2-chloro-2-(diethylamino) ethyl ester, monohydrochloride)... |
Active Ingredient | Chloroprocaine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 2%; 3% |
Market Status | Prescription |
Company | Hospira; Eurohlth Intl |
2 of 2 | |
---|---|
Drug Name | Chloroprocaine hydrochloride |
Drug Label | Nesacaine and Nesacaine-MPF Injections are sterile non pyrogenic local anesthetics. The active ingredient in Nesacaine and Nesacaine-MPF Injections is chloroprocaine HCL (benzoic acid, 4-amino-2-chloro-2-(diethylamino) ethyl ester, monohydrochloride)... |
Active Ingredient | Chloroprocaine hydrochloride |
Dosage Form | Injectable |
Route | Injection |
Strength | 2%; 3% |
Market Status | Prescription |
Company | Hospira; Eurohlth Intl |
Intrathecal anaesthesia
Ocular surface anaesthesia
Epidural anaesthesia
Peripheral nerve block (local anaesthesia by perineural injection)
Intrathecal anaesthesia
Ocular surface anaesthesia
Anesthetics, Local
Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?